Goldport Capital
Overview
Goldport Capital is a Shenzhen-based venture capital firm specializing in early-stage investments in biotechnology and related sectors. The firm focuses on sectors such as advanced manufacturing, new energy, healthcare, and consumer goods. Established in 2014, Goldport Capital has made 55 investments, with its most recent being in Rongxin New Materials on July 15, 2025. Notable exits include Microtech Medical. The firm's portfolio includes companies like CellOrigin Biotech, a company committed to iPSC-derived innate immune cell therapeutics. Goldport Capital's investment strategy emphasizes sectors like biotechnology, healthcare, advanced manufacturing, new energy, and consumer goods. The firm has a history of leading investments in various funding rounds, including seed, Series A, and Series B stages. Its portfolio reflects a commitment to supporting innovative companies in these sectors, contributing to advancements in biotechnology and related industries.
Investment Focus
- Innovative biotechnology solutions
- Strong management teams
- Scalable business models
Portfolio Companies
Reach Goldport Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Goldport Capital
What sectors does Goldport Capital invest in?
Goldport Capital invests in Healthcare, Consumer Goods, Biotechnology, Advanced Manufacturing and New Energy, and is based in Guangdong, China. Goldport Capital is listed as a venture capital in the ConnectSafely investor database.
What stage does Goldport Capital invest at?
Goldport Capital backs companies at Seed, Early Stage, Series A and Series B, writing cheques of 10M - 50M.
Which regions does Goldport Capital invest in?
Goldport Capital invests across China.
What companies has Goldport Capital invested in?
Goldport Capital's portfolio includes CellOrigin Biotech, Rongxin New Materials, Yurucheng, Zinc Core Titanium, Yisite Biotech, Chaoguang Micro, Teyan Semiconductor and Omnivision.
Last updated · Source: ConnectSafely investor database
